Michael Pickard

Michael Pickard has extensive experience in the biostatistics field. Michael currently holds the position of Head of Biostatistics at Intellia Therapeutics, Inc. since April 2022. Before that, they served as Vice President, Biometrics at Black Diamond Therapeutics from April 2021 to April 2022. Prior to that, they were the Executive Director, Biostatistics at Pfizer from January 2020 to March 2021.

From July 2019 to January 2020, Michael worked at Array BioPharma Inc. as an Executive Director, Biostatistics and Statistical Programming. Before that, they held positions as Senior Director, Biostatistics from October 2016 to July 2019 and Director, Biostatistics from September 2015 to October 2016 at the same company.

Michael also has experience at Takeda Oncology, where they worked as an Associate Director, Biostatistics from an unspecified date to September 2015. Prior to that, they were a Principal Biostatistician from an unspecified date to 2011.

Michael'scareer started as a Biostatistician at Millennium Pharmaceuticals, Inc. from an unspecified date to 2008.

Overall, Michael Pickard has a strong background and expertise in biostatistics with progressively senior roles throughout their career.

Michael Pickard attended Boston University, where they earned a Bachelor of Arts degree in Molecular Biology/Biochemistry. Michael also completed a Doctor of Philosophy (PhD) program in Biostatistics at Boston University.